Immunome Inc. Balance Sheet
IMNM / Health Care|7 years of annual SEC 10-K data (FY2019-FY2025)
Shows total assets, cash and equivalents, receivables, property and equipment, total debt, and shareholders' equity across 7 fiscal years. All figures from audited SEC 10-K filings.
Immunome Inc. had $683M in total assets and $634M in shareholders' equity as of FY2025.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score 4.19 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $653.5M | $143.4M | $98.7M | $20.3M | $49.2M | $39.8M | $2.5M |
| Current Assets | $660.8M | $221.3M | $144.7M | $22.6M | $56.6M | $42.9M | $3.1M |
| PP&E (Net) | $14.6M | $10.1M | $2.1M | $681.0K | $855.0K | $1.5M | $1.7M |
| Total Assets | $683.2M | $240.2M | $148.5M | $24.0M | $57.9M | $44.5M | $5.1M |
| Current Liabilities | $45.0M | $54.3M | $21.8M | $7.3M | $9.7M | $3.0M | $1.7M |
| Total Debt | - | - | - | - | - | $134.0K | - |
| Shareholders' Equity | $634.3M | $181.2M | $16.7M | $16.7M | $48.2M | $41.3M | -$35.6M |